QUOTE AND NEWS
Motley Fool  Jan 19  Comment 
Does Opko Health's recent clinical setback hurt it in a head-to-head comparison with Qiagen? Or does it actually help?
Motley Fool  Jan 10  Comment 
The drugmaker's efforts to rapidly expand its business and become a healthcare powerhouse were dealt a blow last month when a key late-stage study failed to pan out.
Forbes  Jan 3  Comment 
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
Benzinga  Jan 3  Comment 
Shares of Opko Health Inc. (NASDAQ: OPK) slumped after the release of mixed results from a Phase III clinical study of long-acting human growth hormone [hGH-CTP] candidate in adults with growth hormone deficiency. “We view the sell off as...
Reuters  Dec 30  Comment 
OPKO Health Inc said its experimental drug for growth hormone deficiency (GHD) in adults failed to provide a statistically significant benefit over a placebo in a late-stage study, sending its shares down about 17 percent on Friday.
Motley Fool  Dec 30  Comment 
A late-stage clinical trial snafu has investors running for the hills.





You may also be interested in articles related to Opko Health Inc (OPK):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki